Transportable Ex Vivo Normothermic Preservation

 

 

 

The metra® device:

  • Recreates a physiological environment
  • Enables up to 24 hour preservation
  • Enables transplantation of steatotic organs*
  • Can improve operating room logistics*
  • Can reduce peak AST in the first week post-transplant compared to cold storage*

Following the UK feasibility study, the OrganOx metra device has now been CE marked, used in a large scale European randomised controlled clinical trial, two feasibility trials in Canada and a large scale US clinical trial has recently started. *Ravikumar et al; Am J Transpl. 2016;16:1779-1787

 

Latest news from OrganOx